Authors
Loading...
Randomized trial evaluates clinical and microbiome changes in Down syndrome patients post-treatment, suggesting beneficial effects.
Shiba et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: